Dec 16, 2019
Heron Therapeutics Announces Publication of the Mechanism of Action Data for HTX-011, a Dual-Acting Local Anesthetic Being Developed for Management of Postoperative Pain
Dec 11, 2019
iX Biopharma Reports on Outcome of Wafermine End-of-phase 2 Meeting with US FDA
Dec 10, 2019
Slayback Pharma announces approval and immediate launch of Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection in 200 mcg/ 50 mL and 400 mcg/ 100 mL (4 mcg/mL) vials, generic equivalent of Precedex(TM) 4 mcg/ mL
Nov 25, 2019
Ketamine Clinics Los Angeles Featured on Emmy® Award-Winning Talk Show The Doctors
Nov 07, 2019
Ketamine Holds Promise in Derailing Veteran Suicide
Oct 08, 2019
CT Psychiatrist Shows Titrated IV Ketamine Can STOP Suicidality
Oct 03, 2019
Pacific Ketamine Institute Introduces SPRAVATO(TM) Treatment for Depression and Mental Disorders
Sep 16, 2019
Dr. David Mahjoubi Announces Move to a New Location for the Ketamine Healing Clinic of Los Angeles
Aug 21, 2019
New Cutting Edge Treatment Center, Klarity Life, Offers Alternative to Traditional Drug & Alcohol Detox Programs
Aug 20, 2019
The Ketamine Healing Clinic of Los Angeles's Dr. David Mahjoubi is Featured in the Mic.com Article, "How Does Ketamine Treat Depression, and is it Safe?"
Aug 16, 2019
IV Ketamine Infusions Dramatically Improve the Quality of Life for Severe Migraine Patient
Jul 23, 2019
Kalypso Wellness Center Patients See 90 Success Rates
Jul 23, 2019
Dallas Gets Infusion Center to Treat Depression, PTSD, Chronic Pain & Addiction
Jun 06, 2019
Pacific Ketamine Institute Launches in Beverly Hills
Jun 03, 2019
Ketamine Healing Clinic Of Los Angeles Offers New Infusion Protocol For The Treatment Of Post-Traumatic Stress Disorder (PTSD)
May 31, 2019
Relmada Therapeutics Presents Development Program of REL1017 for Treatment of Depression at the 2019 American Society of Clinical Psychopharmacology Meeting
May 30, 2019
NeuroRx Reports Phase 2 Efficacy for NRX-101, a Breakthrough Therapy Targeting Suicidal Bipolar Depression
May 24, 2019
Monoethanolamine Hydrochloride (CAS 2002-24-6) Market Research Report 2019 - ResearchAndMarkets.com
May 21, 2019
First Sublingual Ketamine Drug for Treatment of Acute Pain to be Evaluated in End-of-Phase 2 Meeting with FDA
May 20, 2019
Dr. Ashraf Hanna's New Ketamine Protocol Delivers a Complete Sustained Remission in a Patient with Depression and Suicidal Ideation